Fig. 3From: SGLT2i relieve proteinuria in diabetic nephropathy patients potentially by inhibiting renal oxidative stress rather than through AGEs pathwayChanges of AGEs before and after 12-week SGLT2 inhibitors treatment in different UACR levels. AGEs: advanced glycation end productsBack to article page